Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LiFeng Chen

Showing results (231-240 of 236) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 236 results.
Journal of Nanobiotechnology|September 11, 2024
Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritisJiangyi Wu, Jinhui Wu, Wei Xiang, et al.
Cancer Discovery|February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal CancerMehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
Cancer Discovery|June 8, 2021
MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STINGYong Zhang, Qifan Yang, Xiangyu Zeng, et al.
Nature Cancer|September 22, 2022
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinomaXiangyu Zeng, Fei Zhao, Gaofeng Cui, et al.
JAMA|June 4, 2020
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical TrialLing Li, Wei Zhang, Yu Hu, et al.
Signal Transduction and Targeted Therapy|May 10, 2023
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumorsChao Zhang, Qiang Guo, Lifeng Chen, et al.
Pageof 24

Showing results (231-240 of 236) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 236 results.
Journal of Nanobiotechnology|September 11, 2024
Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritisJiangyi Wu, Jinhui Wu, Wei Xiang, et al.
Cancer Discovery|February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal CancerMehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
Cancer Discovery|June 8, 2021
MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STINGYong Zhang, Qifan Yang, Xiangyu Zeng, et al.
Nature Cancer|September 22, 2022
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinomaXiangyu Zeng, Fei Zhao, Gaofeng Cui, et al.
JAMA|June 4, 2020
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical TrialLing Li, Wei Zhang, Yu Hu, et al.
Signal Transduction and Targeted Therapy|May 10, 2023
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumorsChao Zhang, Qiang Guo, Lifeng Chen, et al.
Pageof 24